Too many cancer drugs? Crowded market gives investors pause – Reuters
Reuters |
Too many cancer drugs? Crowded market gives investors pause
Reuters The new therapy using engineered white blood cells has shown anti-tumor activity in the hardest to treat neuroblastoma patients. “The beauty is that it is very specific in targeting the cancer cells, while leaving healthy tissue unharmed,” Straathof … |
